151 related articles for article (PubMed ID: 20836156)
21. Cylindromatosis (Cyld) gene mutation in T cells promotes the development of an IL-9-dependent allergic phenotype in experimental asthma.
Reuter S; Maxeiner J; Meyer-Martin H; Michel A; Baars P; Bopp T; Waisman A; Reissig S; Wehler TC; Schild H; Taube C; Stassen M; Becker M
Cell Immunol; 2016 Oct; 308():27-34. PubMed ID: 27372382
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.
Schoppet M; Henser S; Ruppert V; Stübig T; Al-Fakhri N; Maisch B; Hofbauer LC
J Cell Biochem; 2007 Apr; 100(6):1430-9. PubMed ID: 17171649
[TBL] [Abstract][Full Text] [Related]
23. Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Shinoda K; Nakagawa K; Kosaka T; Tanaka N; Maeda T; Kono H; Mizuno R; Kikuchi E; Miyajima A; Umezawa K; Oya M
Hum Immunol; 2010 Aug; 71(8):763-70. PubMed ID: 20573582
[TBL] [Abstract][Full Text] [Related]
24. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
[TBL] [Abstract][Full Text] [Related]
25. Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium.
Zhang C; Zou X; Leluo G; Xu J; Xiang M
Methods Find Exp Clin Pharmacol; 2008; 30(6):421-9. PubMed ID: 18850043
[TBL] [Abstract][Full Text] [Related]
26. Molecular imaging of NF-kappaB in prostate tissue after systemic administration of IL-1 beta.
Vykhovanets EV; Shukla S; MacLennan GT; Resnick MI; Carlsen H; Blomhoff R; Gupta S
Prostate; 2008 Jan; 68(1):34-41. PubMed ID: 18004768
[TBL] [Abstract][Full Text] [Related]
27. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
[TBL] [Abstract][Full Text] [Related]
28. Preventing immune rejection through gene silencing.
Zhang X; Li M; Min WP
Methods Mol Biol; 2010; 623():357-71. PubMed ID: 20217563
[TBL] [Abstract][Full Text] [Related]
29. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
30. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
[TBL] [Abstract][Full Text] [Related]
31. Norepinephrine Controls Effector T Cell Differentiation through β2-Adrenergic Receptor-Mediated Inhibition of NF-κB and AP-1 in Dendritic Cells.
Takenaka MC; Araujo LP; Maricato JT; Nascimento VM; Guereschi MG; Rezende RM; Quintana FJ; Basso AS
J Immunol; 2016 Jan; 196(2):637-44. PubMed ID: 26663782
[TBL] [Abstract][Full Text] [Related]
32. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
Carreño LJ; Riedel CA; Kalergis AM
Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
[TBL] [Abstract][Full Text] [Related]
33. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
[TBL] [Abstract][Full Text] [Related]
35. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
[TBL] [Abstract][Full Text] [Related]
37. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
[TBL] [Abstract][Full Text] [Related]
39. miR-181d regulates human dendritic cell maturation through NF-κB pathway.
Su XW; Lu G; Leung CK; Liu Q; Li Y; Tsang KS; Zhao SD; Chan DTM; Kung HF; Poon WS
Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28731516
[TBL] [Abstract][Full Text] [Related]
40. Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance.
Baratin M; Foray C; Demaria O; Habbeddine M; Pollet E; Maurizio J; Verthuy C; Davanture S; Azukizawa H; Flores-Langarica A; Dalod M; Lawrence T
Immunity; 2015 Apr; 42(4):627-39. PubMed ID: 25862089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
